SCHEMBL3839635

SCHEMBL3839635

COc1ccc(CSc2[nH]c(COC(C)=O)nc2C(=O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.45
CYP2E1 P05181 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C8 P10632 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2B6 P20813 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP1A2 P05177 1/20 0.44
MAPT P10636 3/20 0.43
GAA P10253 1/20 0.43
CTSB P07858 1/20 0.42
LMNA P02545 1/20 0.42
MMP13 P45452 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8035014 0.88 TARBP2 (0.42) FFAR1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL3841049 0.87 FFAR1 (0.49) FFAR1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL3840799 0.79 FFAR1 (0.46) FFAR1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL8043911 0.76 TARBP2 (0.46) FFAR1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL21312768 0.73 FFAR1 (0.56) FFAR1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL21312521 0.71 FFAR1 (0.53) FFAR1CYP2E1CYP3A4CYP2C8CYP2D6
Acetic Acid SCHEMBL1868801 0.70 ALDH1A1 (0.63) FFAR1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL1871228 0.69 ALDH1A1 (0.62) FFAR1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL112518 0.69 ALDH1A1 (0.62) FFAR1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL16903489 0.69 FFAR1 (0.51) FFAR1CYP2E1CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861247-B1 NOVEL IMIDAZOLE N-BENZYLDIOXOL DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS AVENTIS PHARMA SA (FR) 2009-10-07 EP disclosed
EP-0861247-A1 NOVEL IMIDAZOLE N-BENZYLDIOXOL DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS HOECHST MARION ROUSSEL (FR) 1998-09-02 EP disclosed
WO-1997017339-A1 NOVEL IMIDAZOLE N-BENZYLDIOXOL DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS HOECHST MARION ROUSSEL (FR) 1997-05-15 WO disclosed